Nova Patents
PL2346509T3

Inhalation of levofloxacin for reducing lung inflammation

Abstract

This record has no abstract on file.

Term

3 yearsto projected expiry

Projected expiry 6 October 2029, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

27 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims10

Priority claims
DocumentOfficeKindDate
10349608United States of AmericaP
10349608United States of AmericaP
09740571European Patent Office (EPO)A
2009059740United States of AmericaW
2009059740United States of AmericaW
097405716–––
103496P–––
EP20090740571–––
US20080103496P–––
WO2009US59740–––

Members27

Family members, oldest first
DocumentOfficeKind
US2010087386A1United States of AmericaA1
CA2739893A1CanadaA1
WO2010042549A1World Intellectual Property Organization (WIPO)A1
IL212189D0IsraelD0
EP2346509A1European Patent Office (EPO)A1
CN102325532AChinaA
JP2012505222AJapanA
US8629139B2United States of AmericaB2
US2014105985A1United States of AmericaA1
JP2014159461AJapanA
JP2015044825AJapanA
CN102325532BChinaB
CA2739893CCanadaC
JP2017025106AJapanA
JP6099609B2JapanB2
US2018085462A1United States of AmericaA1
EP2346509B1European Patent Office (EPO)B1
DK2346509T3DenmarkT3
PT2346509TPortugalT
SI2346509T1SloveniaT1
HUE050147T2HungaryT2
HRP20201150T1CroatiaT1
ES2809177T3SpainT3
PL2346509T3This recordPolandT3
US11020481B2United States of AmericaB2
HRP20201150T8CroatiaT8
US2022080047A1United States of AmericaA1